Identification of potential target genes of honokiol in overcoming breast cancer resistance to tamoxifen

BackgroundHonokiol (HON) inhibits epidermal growth factor receptor (EGFR) signaling and increases the activity of erlotinib, an EGFR inhibitor, in human head and neck cancers. In this study, using a bioinformatics approach and in vitro experiments, we assessed the target genes of HON against breast...

全面介紹

書目詳細資料

Principais autores:	Adam Hermawan, Herwandhani Putri, Naufa Hanif, Nurul Fatimah, Heri Himawan Prasetio
格式:	Artigo
語言:	Inglês
出版:	Frontiers Media S.A. 2022-12-01
叢編:	Frontiers in Oncology
主題:	honokiol tamoxifen resistance breast cancer bioinformatics targeted therapy
在線閱讀:	https://www.frontiersin.org/articles/10.3389/fonc.2022.1019025/full
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!